Exosome Isolation Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510247180

Publication Date:

October 16, 2024

Pages:

147

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Exosome Isolation Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Exosome Isolation Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosome Isolation Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Exosome Isolation Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Exosome Isolation Service include Creative Biostructure, AMSBIO, Everzom, System Biosciences, Creative Bioarray, Creative Biolabs, Frontage Labs, Lonza and Creative Proteomics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Exosome Isolation Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Exosome Isolation Service by region & country, by Type, and by Application.
The Exosome Isolation Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Isolation Service.
Market Segmentation
By Company
Creative Biostructure
AMSBIO
Everzom
System Biosciences
Creative Bioarray
Creative Biolabs
Frontage Labs
Lonza
Creative Proteomics
capital biosciences
Miltenyi Biotec
Novus Biologicals
Clara Biotech
Immunostep
ExosomeDx
Irvine Scientific
Beckman Coulter
Stratech
QIAGEN
Lifeasible
Segment by Type:
Precipitation
Size Exclusion Chromatography
Magnetic Beads
Segment by Application
Diagnosis
Drug Delivery
Vaccine Development
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Exosome Isolation Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Exosome Isolation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Exosome Isolation Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Exosome Isolation Service Product Introduction
1.2 Global Exosome Isolation Service Market Size Forecast
1.3 Exosome Isolation Service Market Trends & Drivers
1.3.1 Exosome Isolation Service Industry Trends
1.3.2 Exosome Isolation Service Market Drivers & Opportunity
1.3.3 Exosome Isolation Service Market Challenges
1.3.4 Exosome Isolation Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Exosome Isolation Service Players Revenue Ranking (2023)
2.2 Global Exosome Isolation Service Revenue by Company (2019-2024)
2.3 Key Companies Exosome Isolation Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Exosome Isolation Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Exosome Isolation Service
2.6 Exosome Isolation Service Market Competitive Analysis
2.6.1 Exosome Isolation Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Exosome Isolation Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Isolation Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Precipitation
3.1.2 Size Exclusion Chromatography
3.1.3 Magnetic Beads
3.2 Global Exosome Isolation Service Sales Value by Type
3.2.1 Global Exosome Isolation Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Exosome Isolation Service Sales Value, by Type (2019-2030)
3.2.3 Global Exosome Isolation Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnosis
4.1.2 Drug Delivery
4.1.3 Vaccine Development
4.2 Global Exosome Isolation Service Sales Value by Application
4.2.1 Global Exosome Isolation Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Exosome Isolation Service Sales Value, by Application (2019-2030)
4.2.3 Global Exosome Isolation Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Exosome Isolation Service Sales Value by Region
5.1.1 Global Exosome Isolation Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Exosome Isolation Service Sales Value by Region (2019-2024)
5.1.3 Global Exosome Isolation Service Sales Value by Region (2025-2030)
5.1.4 Global Exosome Isolation Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Exosome Isolation Service Sales Value, 2019-2030
5.2.2 North America Exosome Isolation Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Exosome Isolation Service Sales Value, 2019-2030
5.3.2 Europe Exosome Isolation Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Exosome Isolation Service Sales Value, 2019-2030
5.4.2 Asia Pacific Exosome Isolation Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Exosome Isolation Service Sales Value, 2019-2030
5.5.2 South America Exosome Isolation Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Exosome Isolation Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Exosome Isolation Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Exosome Isolation Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Exosome Isolation Service Sales Value
6.3 United States
6.3.1 United States Exosome Isolation Service Sales Value, 2019-2030
6.3.2 United States Exosome Isolation Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Exosome Isolation Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Exosome Isolation Service Sales Value, 2019-2030
6.4.2 Europe Exosome Isolation Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Exosome Isolation Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Exosome Isolation Service Sales Value, 2019-2030
6.5.2 China Exosome Isolation Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Exosome Isolation Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Exosome Isolation Service Sales Value, 2019-2030
6.6.2 Japan Exosome Isolation Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Exosome Isolation Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Exosome Isolation Service Sales Value, 2019-2030
6.7.2 South Korea Exosome Isolation Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Exosome Isolation Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Exosome Isolation Service Sales Value, 2019-2030
6.8.2 Southeast Asia Exosome Isolation Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Exosome Isolation Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Exosome Isolation Service Sales Value, 2019-2030
6.9.2 India Exosome Isolation Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Exosome Isolation Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Creative Biostructure
7.1.1 Creative Biostructure Profile
7.1.2 Creative Biostructure Main Business
7.1.3 Creative Biostructure Exosome Isolation Service Products, Services and Solutions
7.1.4 Creative Biostructure Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.1.5 Creative Biostructure Recent Developments
7.2 AMSBIO
7.2.1 AMSBIO Profile
7.2.2 AMSBIO Main Business
7.2.3 AMSBIO Exosome Isolation Service Products, Services and Solutions
7.2.4 AMSBIO Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.2.5 AMSBIO Recent Developments
7.3 Everzom
7.3.1 Everzom Profile
7.3.2 Everzom Main Business
7.3.3 Everzom Exosome Isolation Service Products, Services and Solutions
7.3.4 Everzom Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.3.5 System Biosciences Recent Developments
7.4 System Biosciences
7.4.1 System Biosciences Profile
7.4.2 System Biosciences Main Business
7.4.3 System Biosciences Exosome Isolation Service Products, Services and Solutions
7.4.4 System Biosciences Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.4.5 System Biosciences Recent Developments
7.5 Creative Bioarray
7.5.1 Creative Bioarray Profile
7.5.2 Creative Bioarray Main Business
7.5.3 Creative Bioarray Exosome Isolation Service Products, Services and Solutions
7.5.4 Creative Bioarray Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.5.5 Creative Bioarray Recent Developments
7.6 Creative Biolabs
7.6.1 Creative Biolabs Profile
7.6.2 Creative Biolabs Main Business
7.6.3 Creative Biolabs Exosome Isolation Service Products, Services and Solutions
7.6.4 Creative Biolabs Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.6.5 Creative Biolabs Recent Developments
7.7 Frontage Labs
7.7.1 Frontage Labs Profile
7.7.2 Frontage Labs Main Business
7.7.3 Frontage Labs Exosome Isolation Service Products, Services and Solutions
7.7.4 Frontage Labs Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.7.5 Frontage Labs Recent Developments
7.8 Lonza
7.8.1 Lonza Profile
7.8.2 Lonza Main Business
7.8.3 Lonza Exosome Isolation Service Products, Services and Solutions
7.8.4 Lonza Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.8.5 Lonza Recent Developments
7.9 Creative Proteomics
7.9.1 Creative Proteomics Profile
7.9.2 Creative Proteomics Main Business
7.9.3 Creative Proteomics Exosome Isolation Service Products, Services and Solutions
7.9.4 Creative Proteomics Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.9.5 Creative Proteomics Recent Developments
7.10 capital biosciences
7.10.1 capital biosciences Profile
7.10.2 capital biosciences Main Business
7.10.3 capital biosciences Exosome Isolation Service Products, Services and Solutions
7.10.4 capital biosciences Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.10.5 capital biosciences Recent Developments
7.11 Miltenyi Biotec
7.11.1 Miltenyi Biotec Profile
7.11.2 Miltenyi Biotec Main Business
7.11.3 Miltenyi Biotec Exosome Isolation Service Products, Services and Solutions
7.11.4 Miltenyi Biotec Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.11.5 Miltenyi Biotec Recent Developments
7.12 Novus Biologicals
7.12.1 Novus Biologicals Profile
7.12.2 Novus Biologicals Main Business
7.12.3 Novus Biologicals Exosome Isolation Service Products, Services and Solutions
7.12.4 Novus Biologicals Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.12.5 Novus Biologicals Recent Developments
7.13 Clara Biotech
7.13.1 Clara Biotech Profile
7.13.2 Clara Biotech Main Business
7.13.3 Clara Biotech Exosome Isolation Service Products, Services and Solutions
7.13.4 Clara Biotech Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.13.5 Clara Biotech Recent Developments
7.14 Immunostep
7.14.1 Immunostep Profile
7.14.2 Immunostep Main Business
7.14.3 Immunostep Exosome Isolation Service Products, Services and Solutions
7.14.4 Immunostep Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.14.5 Immunostep Recent Developments
7.15 ExosomeDx
7.15.1 ExosomeDx Profile
7.15.2 ExosomeDx Main Business
7.15.3 ExosomeDx Exosome Isolation Service Products, Services and Solutions
7.15.4 ExosomeDx Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.15.5 ExosomeDx Recent Developments
7.16 Irvine Scientific
7.16.1 Irvine Scientific Profile
7.16.2 Irvine Scientific Main Business
7.16.3 Irvine Scientific Exosome Isolation Service Products, Services and Solutions
7.16.4 Irvine Scientific Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.16.5 Irvine Scientific Recent Developments
7.17 Beckman Coulter
7.17.1 Beckman Coulter Profile
7.17.2 Beckman Coulter Main Business
7.17.3 Beckman Coulter Exosome Isolation Service Products, Services and Solutions
7.17.4 Beckman Coulter Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.17.5 Beckman Coulter Recent Developments
7.18 Stratech
7.18.1 Stratech Profile
7.18.2 Stratech Main Business
7.18.3 Stratech Exosome Isolation Service Products, Services and Solutions
7.18.4 Stratech Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.18.5 Stratech Recent Developments
7.19 QIAGEN
7.19.1 QIAGEN Profile
7.19.2 QIAGEN Main Business
7.19.3 QIAGEN Exosome Isolation Service Products, Services and Solutions
7.19.4 QIAGEN Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.19.5 QIAGEN Recent Developments
7.20 Lifeasible
7.20.1 Lifeasible Profile
7.20.2 Lifeasible Main Business
7.20.3 Lifeasible Exosome Isolation Service Products, Services and Solutions
7.20.4 Lifeasible Exosome Isolation Service Revenue (US$ Million) & (2019-2024)
7.20.5 Lifeasible Recent Developments
8 Industry Chain Analysis
8.1 Exosome Isolation Service Industrial Chain
8.2 Exosome Isolation Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Exosome Isolation Service Sales Model
8.5.2 Sales Channel
8.5.3 Exosome Isolation Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Creative Biostructure
AMSBIO
Everzom
System Biosciences
Creative Bioarray
Creative Biolabs
Frontage Labs
Lonza
Creative Proteomics
capital biosciences
Miltenyi Biotec
Novus Biologicals
Clara Biotech
Immunostep
ExosomeDx
Irvine Scientific
Beckman Coulter
Stratech
QIAGEN
Lifeasible

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂